Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Conmed (CNMD) Interest Expenses (2016 - 2025)

Conmed (CNMD) has disclosed Interest Expenses for 4 consecutive years, with -$2.6 million as the latest value for Q1 2022.

  • For the quarter ending Q1 2022, Interest Expenses changed N/A year-over-year to -$2.6 million, compared with a TTM value of -$2.6 million through Dec 2022, changed N/A, and an annual FY2025 reading of $31.1 million, changed N/A over the prior year.
  • Interest Expenses was -$2.6 million for Q1 2022 at Conmed, down from $3.9 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $3.9 million in Q1 2019 and bottomed at -$2.6 million in Q1 2022.